Data protection Impressum

Pharma

Certification Experts, a division of Kader Group, has opened a new office on Lausanne's Biopôle campus, reinforcing its presence in Switzerland to meet rising demand for compliance and regulatory consulting in the medical device and pharmaceutical sectors.

Certification Experts expands medtech services with new office at Biopôle

28 October 2024

Lonza expands its collaboration with a major biopharma partner, adding a new bioconjugation suite in Visp to support advanced cancer therapy manufacturing.

Lonza expands its manufacturing capabilities in Visp and creates 100 new jobs

23 October 2024

Nestled in the quiet industrial zone of Domdidier, in the canton of Fribourg, Medistri has grown into a key player in the highly specialized field of sterilization for medical and pharmaceutical industries.

Medistri, Fribourg’s hidden champion in medtech and pharmaceutical sterilization

22 October 2024

Phoenix Pharma Switzerland has announced the relocation of its Swiss headquarters to the Businesspark Liebefeld in Köniz, bringing 100 new jobs to the canton of Bern.

Phoenix Pharma Switzerland relocates its headquarters to the canton of Bern

2 October 2024

A Memorandum of Understanding (MOU) between KoreaBIO and the Switzerland Innovation Park West EPFL was signed during the Korea-Switzerland Partnering Day, strengthening industrial cooperation and joint research in biotech.

Switzerland strengthens biotech collaboration with KoreaBIO through new MOU

30 September 2024

ten23 health celebrates the opening of its VIVA2® facility in Visp, increasing the region's sterile pharmaceutical production capacity and strengthening its position in the life sciences sector.

ten23 health inaugurates VIVA2 sterile production facility in Visp

24 September 2024

HAYA Therapeutics has announced a multi-year collaboration with Eli Lilly, potentially earning up to USD 1 billion in milestone payments to advance RNA-guided therapies for obesity and metabolic disorders.

HAYA Therapteutics enters major collaboration to advance RNA-based drug discovery

17 September 2024

Relief Therapeutics has entered into an agreement with SWK Funding LLC to secure up to USD 11 million in non-dilutive financing through the sale of royalty interests to support its clinical development pipeline.

Geneva biotech Relief Therapeutics raises up to USD 11 million from royalty sales

14 August 2024

Release Therapeutics has raised CHF 3.3 million in seed funding to advance its innovative approach to treating metachromatic leukodystrophy (MLD), a rare genetic disorder affecting young children.

Release Therapeutics secures CHF 3.3 million to advance MLD research

13 August 2024

Oryl Photonics has joined the Fast and Accurate Solubility for Sustainability (FASS) project, receiving a EUR 2.5 million EIC Transition grant to develop a novel laboratory instrument for drug solubility measurement.

EPFL spin-off Oryl Photonics joins a EUR 2.5 million European project

7 August 2024

1 2 3 4 5 6 7 8 … 15